Overview

Greater Occipital Nerve (GON) Block Effectivity in the Treatment of Chronic Migraine: 6 Months Follow up

Status:
Withdrawn
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
This study evaluates effectiveness of greater occipital nerve blocks with bupivacaine compared to placebo in chronic migraine patients.
Phase:
Phase 4
Details
Lead Sponsor:
Bozok University
Treatments:
Bupivacaine